نتایج جستجو برای: vascular endothelial growth factor receptor vegfr

تعداد نتایج: 2100982  

Journal: :Circulation research 2007
Ganapati H Mahabeleshwar Weiyi Feng Kumar Reddy Edward F Plow Tatiana V Byzova

The functional responses of endothelial cells are dependent on signaling from peptide growth factors and the cellular adhesion receptors, integrins. These include cell adhesion, migration, and proliferation, which, in turn, are essential for more complex processes such as formation of the endothelial tube network during angiogenesis. This study identifies the molecular requirements for the cros...

Journal: :The Annals of otology, rhinology, and laryngology 2005
Reza Rahbar Sara O Vargas Judah Folkman Trevor J McGill Gerald B Healy Xiaolian Tan Lawrence F Brown

Vascular endothelial growth factor-A (VEGF-A) is known to play an important role in the angiogenic response essential for tumor growth in a variety of human and experimental tumors. This study was designed to investigate whether VEGF-A may play a role in the pathogenesis of recurrent respiratory papillomatosis (RRP). A retrospective study with institutional review board approval was performed a...

Journal: :journal of basic and clinical pathophysiology 2015
fatemeh hajghasemi abbas mirshafiey

background and objective: vascular endothelial growth factor (vegf) is a cytokine which is overexpressed in many malignant cancers including leukemia. vegf plays an important role in tumor invasion and metastasis. determination of the pattern of vegf expression in human leukemic cell lines could be useful not only in screening of new antileukemic agents but also to study the mechanism of their ...

Journal: :Anticancer research 2005
Manabu Akahane Takemi Akahane Amy Shah Eijiro Okajima Unnur P Thorgeirsson

BACKGROUND Vascular endothelial growth factor-D (VEGF-D) binds and activates vascular endothelial growth factor receptor-2 (VEGFR-2), which signals for angiogenesis, and VEGFR-3, which signals for lymphangiogenesis. Besides endothelial cells, VEGFR-2 has been detected on malignant cells, including human breast carcinoma cells. MATERIALS AND METHODS It was examined if ectopic expression of hum...

Journal: :Circulation research 2004
Gerald W Prager Johannes M Breuss Stefan Steurer Damla Olcaydu Judit Mihaly Patrick M Brunner Hannes Stockinger Bernd R Binder

The angiogenic response of endothelial cells initiated by different growth factors is accompanied by assembly of cell surface-bound proteolytic machinery as a prerequisite for focal invasion. We have shown previously how the vascular endothelial growth factor (VEGF) initiates proteolysis by activation of pro-urokinase (pro-PA) via the VEGF receptor-2 (VEGFR-2). We now show that the cell surface...

Journal: :iranian red crescent medical journal 0
moslem jafari sani biochemistry department, school of medicine, shahroud university of medical sciences, shahroud, ir iran foad yazdi biotechnology department, faculty of medicine, tehran university of medical sciences, tehran, ir iran masoomeh masoomi karimi immunology department, school of medicine, torbat heydariyeh university of medical sciences, torbat heydariyeh, ir iran javad alizadeh department of molecular medicine, biotechnology research center, pasteur institute of iran, tehran, ir iran majid rahmati biotechnology department, faculty of medicine, tehran university of medical sciences, tehran, ir iran ali zarei mahmudabadi biochemical department, chemical injuries research center, baqiyatallah university of medical sciences, tehran, ir iran; biochemical department, chemical injuries research center, baqiyatallah university of medical sciences, tehran, ir iran. tel: +98-9123277532, fax: +98-2122830262

background angiogenesis is an important biological process involved in the proliferation of endothelial cells, tumor growth and metastasis. vascular endothelial growth factor (vegf) is considered as a prominent regulator of angiogenesis which exerts the aforementioned effect(s) through its respective receptors (vegfr1 and vegfr2). vegf receptors are targeted as a therapeutic candidate for cance...

ژورنال: پژوهش در پزشکی 2011
بهدانی, مهدی, حبیبی انبوهی, مهدی, زینلی, سیروس, کریمی پور, مرتضی, آزادمنش, کیهان , اسدزاده, نادر , خان احمد, حسین , خبیری, علیرضا ,

Abstract Background: In molecular approach, serum of camel contains a unique type of antibodies devoid of light chains since the light chain is missing, the heavy-chain antibodies should bind their antigen by one single domain, the variable domain of the heavy immunoglobulin chain. Vascular endothelial growth factor receptor-2 (VEGFR-2) is one of the important proteins in angiogenesis which...

Journal: :Cancer research 2005
Kenji Yokoi Takamitsu Sasaki Corazon D Bucana Dominic Fan Cheryl H Baker Yasuhiko Kitadai Toshio Kuwai James L Abbruzzese Isaiah J Fidler

Although gemcitabine has been approved as the first-line chemotherapeutic reagent for pancreatic cancer, its response rate is low and average survival duration is still only marginal. Because epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), and platelet-derived growth factor receptor (PDGFR) modulate tumor progression, we hypothesized that inhibition...

Journal: :The Journal of biological chemistry 2006
Mathew A von Wronski Natarajan Raju Radhakrishna Pillai Nancy J Bogdan Edmund R Marinelli Palaniappa Nanjappan Kondareddiar Ramalingam Thangavel Arunachalam Steve Eaton Karen E Linder Feng Yan Sibylle Pochon Michael F Tweedle Adrian D Nunn

Tuftsin, Thr-Lys-Pro-Arg (TKPR), is an immunostimulatory peptide with reported nervous system effects as well. We unexpectedly found that tuftsin and a higher affinity antagonist, TKPPR, bind selectively to neuropilin-1 and block vascular endothelial growth factor (VEGF) binding to that receptor. Dimeric and tetrameric forms of TKPPR had greatly increased affinity for neuropilin-1 based on comp...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید